Cosmos Health (COSM) Common Equity (2011 - 2026)

Cosmos Health (COSM) has reported Common Equity for 16 consecutive years, with $20.7 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Common Equity fell 21.18% year-over-year to $20.7 million; the trailing twelve-month figure through Jun 2026 stood at $20.7 million (down 21.18% YoY), and the FY2025 full-year result was $18.4 million, down 24.9% from the prior year.
• Common Equity improved to $20.7 million in Q2 2026 per COSM's latest filing, from $19.8 million in the prior quarter.
• Across five years, Common Equity topped out at $1.5 billion in Q3 2025 and bottomed at $3.4 million in Q3 2022.
• Historically, Common Equity has averaged $108.8 million across 5 years, with a median of $29.2 million in 2024.
• The sharpest annual moves came in 2024 and 2025: Common Equity slumped 31.93% in 2024, then soared 4188.58% in 2025.
• Over 5 years, Common Equity stood at $39.3 million in 2022, then retreated by 8.25% to $36.0 million in 2023, then plunged by 31.93% to $24.5 million in 2024, then retreated by 24.9% to $18.4 million in 2025, then gained by 12.21% to $20.7 million in 2026.
• According to Business Quant data, Common Equity over the past three periods registered $20.7 million, $19.8 million, and $18.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.